Wetenschappelijke publicaties

1. Kharagjitsing HHS, Hendriksz TR, Fouraux MA, van Gelder T, van Bommel EFH. Clinical significance of soluble interleukin-2 receptor measurement in patients with idiopathic retroperitoneal fibrosis. Int Urol Nephrol. 2022 Mar 31. doi: 10.1007/s11255-022-03196-3.

2. Kharagjitsing HHS, van Vooren J, Brilman EG, Hendriksz TR, van Gelder T, van Bommel EFH. Abdominal aortic diameter and cardiovascular status in patients with idiopathic retroperitoneal fibrosis. Rheumatol Int. 2021 Nov 25. doi: 10.1007/s00296-021-05051-7.

3. Buijs SM, Hendriksz TR, van Bommel EFH. Retroperitoneal fibrosis after spinal surgery: a report of 2 cases. JBJS Case Connect. 2021 Oct 27;11(4). doi: 10.2106/JBJS.CC.21.00269.

4. Kharagjitsing H, van Eekeren R, van Puijenbroek EP, van Gelder T, van Bommel EFH. Retroperitoneal fibrosis and β-blocking agents: Is there an association? Br J Clin Pharmacol. 2021;1–11. https://doi.org/10.1111/bcp.14702.

3. Pieter J. Westenend, Robert C. Akkers, Nienke Katier, Eric FH van Bommel. Erdheim Chester disease presenting as sclerosing mesenteritis. J Hematopathol. (2021). https://doi.org/10.1007/s12308-020-00438-0.

4. J-Matthias Löhr, Ulrich Beuers, Miroslav Vujasinovic, Domenico Alvaro, Jens Brøndum Frøkjær, Frank Buttgereit, Gabriele Capurso, Emma L Culver, Enrique de-Madaria, Emanuel Della-Torre, Sönke Detlefsen, Enrique Dominguez-Muñoz, Piotr Czubkowski, Nils Ewald, Luca Frulloni, Natalya Gubergrits, Deniz Guney Duman, Thilo Hackert, Julio Iglesias-Garcia, Nikolaos Kartalis, Andrea Laghi, Frank Lammert, Fredrik Lindgren, Alexey Okhlobystin, Grzegorz Oracz, Andrea Parniczky, Raffaella Maria Pozzi Mucelli, Vinciane Rebours, Jonas Rosendahl, Nicolas Schleinitz, Alexander Schneider, Eric FH van Bommel, Caroline Sophie Verbeke, Marie Pierre Vullierme, Heiko Witt, and UEG guideline working group. European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. United European Gastroenterol J. 2020 Jul;8(6):637-666. doi: 10.1177/2050640620934911. Epub 2020 Jun 18

5. Eske A van Baalen, Tadek R Hendriksz, Boudewijn Brans, Pieter J Westenend, Eric FH van Bommel. Intimal angiosarcoma masquerading as retroperitoneal fibrosis. VASA (2020). https://doi.org/10.1024/0301-1526/a000889.

6. Pegoraro F, Maniscalco V, Peyronel F, Westenend PJ, Hendriksz TR, Roperto RM, Palumbo AA, Sieni E, Romagnani P, van Bommel EFH, Vaglio A. Long-term follow-up of mTOR inhibition for Erdheim-Chester disease. Blood. 2020 May 28;135(22):1994-1997. doi: 10.1182/blood.2019004478. PMID: 32299103.

7. Van Bommel EFH, van der Zijden MA, Elgersma OEH, Hendriksz TH. Debilitating Venous Claudication Secondary to Retroperitoneal Fibrosis. J Clin Rheumatol. 2020 Oct;26(7):e225-e227. doi: 10.1097/RHU.0000000000001091.

8. van Bommel EFH, van der Zijden MA, Smak Gregoor PJH, Hendriksz TR, Ho-Han SH, Westenend PJ. Sirolimus monotherapy for Erdheim-Chester disease. Acta Oncol. 2019 Jun;58(6):901-905. doi: 10.1080/0284186X.2019.1589648. Epub 2019 Mar 28.

9. Martorana D, Márquez A, Carmona FD, Bonatti F, Adorni A, Urban ML, Maritati  F, Accorsi Buttini E, Marvisi C, Palmisano A, Rossi GM, Trivioli G, Fenaroli P, Manenti L, Nicastro M, Incerti M, Gianfreda D, Bani S, Ferretti S, Corradi D, Alberici F, Emmi G, Di Scala G, Moroni G, Percesepe A, Scheel PJ Jr, Vermeer HJ, van Bommel EF, Martín J, Vaglio A. A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis. J Allergy Clin Immunol. 2018 Aug 4. pii: S0091-6749(18)31074-1. doi: 10.1016/j.jaci.2018.06.045.

10. Pelkmans LG, Hendriksz TR, Westenend PJ, Vermeer HJ, van Bommel EF. Elevated serum IgG4 levels in diagnosis and treatment response in patients with idiopathic retroperitoneal fibrosis. Clin Rheumatol. 2017 Apr;36(4):903-912. doi: 10.1007/s10067-017-3542-8.

11. Eric F.H. van Bommel & Nienke van Putte-Katier. Chapter 11: Sclerosing mesenteritis, pg 137-153. In:  Augusto Vaglio, editor. Systemic fibro-inflammatory disorders. Springer Verlag, march 2017 (ISBN 978-3-319-41347-1)

12. van der Bilt FE, Hendriksz TR, van der Meijden WAG, Brilman LG, van Bommel EFH. Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapy. Clin Kidney J. 2016 Apr;9(2):184-91. doi: 10.1093/ckj/sfv148. Epub 2016 Jan 18.

13. van Putte-Katier N, van Bommel EFH, Elgersma OE, Hendriksz TR Mesenteric panniculitis: prevalence, clinicoradiological presentation and 5-year follow-up. Br J Radiol. 2014 Dec;87(1044):20140451.doi: 10.1259/bjr.20140451.Epub 2014 Oct 1

14. Mertens S, Zeegers AGM, Wertheimer PA, Hendriksz TR, van Bommel EFH. Efficacy and complications of urinary drainage procedures in idiopathic retroperitoneal fibrosis complicated by extrinsic ureteral obstruction. Int J Urol 2014;21(3):283-288.

15. van Bommel, Eric. Retroperitoneal Fibrosis. (Engelstalig wetenschappelijk boek, 243 pg). April 2013, ISBN/EAN: 987-90-820240-0-5.

16. van Bommel EF, Pelkmans LG, van Damme H, Hendriksz TR. Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis. Eur J Intern Med. 2013;24(5): 444-450

17. Pelkmans L, Aarnoudse AL, Hendriksz TR, van Bommel EFH. Value of acute-phase reactants in monitoring disease activity and treatment respons in idiopathic retroperitoneal fibrosis. Nephrol Dial Transplant;2012;27:2819-25.

18. van Bommel EFH, de Mol M, Langerak A, Westenend PJ. Idiopathic retroperitoneal fibrosis mimicking malignant lymphoma. Path Int. 2011;61:672-676.

19. van Bommel EFH, van Tits LJ, van den Berg EA, Prins J, Stalenhoef AF. Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case-control study. Rheumatol Int. 2011 Feb;31(2):201-8.

20. Jansen I, Hendriksz TR, Van Bommel EFH. Pseudocyst formation in retroperitoneal fibrosis relapse. Br J Radiol. 2010;83:111-113.

21. Jansen I, Hendriksz TR, Han SH, Huiskes AW, van Bommel EFH. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Eur J Intern Med. 2010;21:216-21.

22. van Bommel EFH, Jansen I, Hendriksz TR, Aarnoudse AL. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore). 2009;88:193-201.

23. van Bommel EFH, van der Veer SJ, Hendriksz TR, Bleumink GS. Persistent chronic peri-aortitis ('inflammatory aneurysm') after abdominal aortic aneurysm repair: systematic review of the literature. Vasc Med. 2008 Nov;13(4):293-303.

24. van Bommel EFH, Siemes C, van der Veer SJ, Han SH, Huiskes AW, Hendriksz TR.Clinical value of gallium-67 SPECT scintigraphy in the diagnostic and therapeutic evaluation of retroperitoneal fibrosis: a prospective study. J Intern Med. 2007 Aug;262(2):224-34.

25. van Bommel EFH, Siemes C, Hak LE, van der Veer SJ, Hendriksz TR. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis. 2007 May;49(5):615-25.

26. van Bommel EFH, Hendriksz TR, Huiskes AWLC, Zeegers AGM. Tamoxifen therapy for non-malignant retroperitoneal fibrosis. Ann Intern Med. 2006;144:101-106.

27. van Bommel EFH. Retroperitoneal fibrosis. Neth J Med. 2002;60:231-242.

28. van Bommel EFH, Brouwers AWJ, Makkus L, van Vliet ACM. Idiopathic retroperitoneal fibrosis and p-ANCA associated polyarteritis nodosa: Co-incidence or Common Etiology? Eur J Intern Med. 2002;13:392-395.

29. van Bommel EFH, Bouvy N, Liem E, Boeve ER, Weimar W. Coexistent retroperitoneal and mediastinal fibrosis presenting with portal hypertension. Neth J Med. 1994;44:¬174-177.

30. van Bommel EFH, Boeve ER, Weimar W. Retroperitoneal fibrosis: current concepts. Eur Urol Update Series 1993;2(3):17-23.

31. van Bommel EFH, van Spengler J, van der Hoven B, Kramer P. Retroperitoneal fibrosis: Report of 12 cases and a review of the literature. Neth J Med. 1991;39:338-345.